NeuroSave is a clinical-stage medical device company offering fast, non-surgical brain-targeted cooling that is intended to prevent and treat brain injury from surgery, stroke, cardiac arrest and trauma. In addition, this therapy will reduce unwanted risks associated with whole-body cooling by focusing therapeutic hypothermia to the brain in contrast to the catheters and skin pads marketed today. Speed is critical to maximize cooling’s benefits - lost time equals lost brain tissue.
In a clinical trial, NeuroSave cooled the brain more than 15 times faster than current market-leading technology and maintained the brain up to 3.5°C colder than the body – clinically relevant temperature reduction. NeuroSave is the only non-surgical therapy proven to reach therapeutically relevant brain temperatures in under 15 minutes.
